X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12804) 12804
Book Review (3474) 3474
Publication (602) 602
Book / eBook (115) 115
Book Chapter (78) 78
Magazine Article (41) 41
Newsletter (31) 31
Conference Proceeding (30) 30
Dissertation (11) 11
Newspaper Article (5) 5
Trade Publication Article (5) 5
Paper (2) 2
Web Resource (2) 2
Data Set (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9655) 9655
humans (9289) 9289
female (4706) 4706
administration, oral (4468) 4468
male (4450) 4450
warfarin (4334) 4334
anticoagulants (3774) 3774
aged (3663) 3663
anticoagulants - administration & dosage (3496) 3496
anticoagulants - therapeutic use (3297) 3297
middle aged (3214) 3214
atrial fibrillation (3159) 3159
anticoagulants - adverse effects (2558) 2558
risk factors (2553) 2553
stroke (2345) 2345
cardiac & cardiovascular systems (2319) 2319
oral anticoagulation (2301) 2301
hematology (2263) 2263
peripheral vascular disease (2093) 2093
adult (1995) 1995
treatment outcome (1969) 1969
atrial fibrillation - drug therapy (1801) 1801
aged, 80 and over (1775) 1775
thromboembolism (1751) 1751
oral anticoagulants (1750) 1750
dabigatran (1748) 1748
management (1641) 1641
therapy (1638) 1638
prevention (1622) 1622
abridged index medicus (1610) 1610
anticoagulation (1559) 1559
risk (1544) 1544
rivaroxaban (1516) 1516
venous thromboembolism (1492) 1492
atrial-fibrillation (1464) 1464
international normalized ratio (1462) 1462
hemorrhage - chemically induced (1459) 1459
stroke - prevention & control (1439) 1439
medicine, general & internal (1349) 1349
atrial fibrillation - complications (1310) 1310
warfarin - therapeutic use (1243) 1243
pharmacology & pharmacy (1230) 1230
thrombosis (1224) 1224
warfarin - administration & dosage (1162) 1162
surgery (1122) 1122
retrospective studies (1112) 1112
medicine & public health (1066) 1066
care and treatment (1061) 1061
stroke prevention (994) 994
warfarin - adverse effects (992) 992
analysis (984) 984
time factors (981) 981
apixaban (955) 955
bleeding (949) 949
drug therapy (948) 948
antithrombotic therapy (943) 943
thromboembolism - prevention & control (897) 897
risk assessment (892) 892
oral anticoagulant-therapy (870) 870
stroke - etiology (851) 851
prospective studies (845) 845
aspirin (827) 827
patients (817) 817
cardiac arrhythmia (810) 810
cardiology (804) 804
safety (804) 804
hemorrhage (803) 803
vitamin k - antagonists & inhibitors (785) 785
mortality (776) 776
follow-up studies (770) 770
deep-vein thrombosis (766) 766
blood coagulation - drug effects (732) 732
internal medicine (692) 692
molecular-weight heparin (692) 692
direct oral anticoagulants (690) 690
risk-factors (678) 678
metaanalysis (658) 658
health aspects (641) 641
dosage and administration (634) 634
dose-response relationship, drug (625) 625
research (608) 608
dentistry (592) 592
adolescent (589) 589
thrombin (582) 582
animals (543) 543
clinical trials (537) 537
incidence (537) 537
complications (532) 532
medical research (530) 530
cardiovascular (524) 524
efficacy (522) 522
dentistry, oral surgery & medicine (518) 518
guidelines (518) 518
anticoagulants - pharmacology (512) 512
prothrombin time (509) 509
drug administration schedule (507) 507
fibrillation (500) 500
recurrence (482) 482
pulmonary embolism (478) 478
usage (473) 473
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (51) 51
Dentistry (Harry R Abbott) - Stacks (29) 29
Gerstein Science - Stacks (28) 28
Dentistry (Harry R Abbott) - Withdrawn (16) 16
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (14) 14
Dentistry (Harry R Abbott) - Circulation Desk (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Lakeridge Health Sciences - Oshawa (2) 2
Scarborough Hospital - Birchmount (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - May be requested (1) 1
Dentistry (Harry R Abbott) - Searching (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Online Resources - Online (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11877) 11877
German (467) 467
Spanish (247) 247
French (240) 240
Portuguese (55) 55
Italian (37) 37
Russian (37) 37
Japanese (32) 32
Polish (22) 22
Korean (11) 11
Hungarian (9) 9
Chinese (7) 7
Turkish (7) 7
Dutch (6) 6
Norwegian (6) 6
Czech (5) 5
Arabic (4) 4
Hebrew (4) 4
Croatian (2) 2
Danish (2) 2
Finnish (2) 2
Romanian (2) 2
Serbian (2) 2
Georgian (1) 1
Lithuanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 06/2012, Volume 107, Issue 6, pp. 1053 - 1065
Journal Article
Circulation, ISSN 0009-7322, 11/2012, Volume 126, Issue 19, pp. 2309 - 2316
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 190, pp. 12 - 18
Background Oral anticoagulation prevents ischemic strokes in patients with atrial fibrillation. Early detection of atrial fibrillation and subsequent... 
Cardiovascular | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | STROKE PREVENTION | WARFARIN | CLINICAL-IMPLICATIONS | AMERICAN-COLLEGE | CARDIAC MONITOR | RISK | OPEN-LABEL | TEMPORAL RELATIONSHIP | ISCHEMIC-STROKE | Prospective Studies | Follow-Up Studies | Humans | Male | Thiazoles - administration & dosage | Atrial Fibrillation - physiopathology | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Time Factors | Female | Stroke - epidemiology | Vitamin K | Heart Rate | Stroke - prevention & control | Pyridines - administration & dosage | Survival Rate - trends | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Europe - epidemiology | Treatment Outcome | Disease-Free Survival | Stroke - etiology | Atrial Fibrillation - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Stroke patients | Atrial fibrillation | Cardiac patients | Implants, Artificial | Prosthesis | Anticoagulants | Therapy | Cardiac arrhythmia | Surgical implants | Aspirin | Stroke | Coagulation | Strokes | Patients | Bleeding | Risk factors | Vitamins | Artifacts | Fibrillation | Ischemia | Defibrillators | Pacemakers | Safety engineering | Electrocardiography | Heart diseases | Index Medicus | Abridged Index Medicus | Trial Design
Journal Article
Circulation, ISSN 0009-7322, 02/2015, Volume 131, Issue 5, pp. 488 - 494
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 3, pp. 625 - 632
In patients with atrial fibrillation (AF) who require interruption of dabigatran or warfarin for an elective surgery/procedure, the risks and benefits of... 
Warfarin | Dabigatran | Bridging anticoagulation | Surgery | PREDICTING STROKE | MANAGEMENT | ORAL ANTICOAGULATION | RISK | CLASSIFICATION | OPEN-LABEL | I TREAT | warfarin | ATRIAL-FIBRILLATION | THERAPY | ETEXILATE | dabigatran | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | surgery | Perioperative Care | Multivariate Analysis | Dabigatran - adverse effects | Dabigatran - administration & dosage | Anticoagulants - administration & dosage | Postoperative Hemorrhage - prevention & control | Humans | Middle Aged | Warfarin - adverse effects | Male | Warfarin - administration & dosage | Time Factors | Adult | Female | Retrospective Studies | Atrial Fibrillation - diagnosis | Odds Ratio | Surgical Procedures, Operative - adverse effects | Blood Loss, Surgical - prevention & control | Stroke - prevention & control | Drug Administration Schedule | Risk Assessment | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | Proportional Hazards Models | Logistic Models | Treatment Outcome | Anticoagulants - adverse effects | Randomized Controlled Trials as Topic | Postoperative Hemorrhage - etiology | Propensity Score | Stroke - etiology | Aged | Elective Surgical Procedures | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2017, Volume 120, Issue 5, pp. 792 - 796
Abstract In the ENSURE-AF study (NCT 02072434), edoxaban was compared to enoxaparin–warfarin in 2199 patients undergoing electrical cardioversion of... 
Cardiovascular | STROKE | THERAPEUTIC RANGE | CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULANT | QUALITY ANTICOAGULATION | PREDICT | RISK | SAME-TT2R2 SCORE | TIME | OUTCOMES | SPORTIF TRIALS | Single-Blind Method | Stroke - prevention & control | Prospective Studies | Pyridines - administration & dosage | Anticoagulants - administration & dosage | Follow-Up Studies | Atrial Fibrillation - therapy | Humans | Middle Aged | Atrial Fibrillation - complications | Electric Countershock | Male | Thiazoles - administration & dosage | Treatment Outcome | Warfarin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Enoxaparin - administration & dosage | Stroke - etiology | Female | Drug Therapy, Combination | Stroke (Disease) | Hypertension | Care and treatment | Analysis | Atrial fibrillation | Anticoagulants (Medicine) | Electric countershock | Smoking | Myocardial infarction | Heart | Drugs | Cardiac arrhythmia | Transient ischemic attack | Renal function | Liver | Medical services | Alcohol | Congestive heart failure | Bleeding | Confidence intervals | Ratios | Randomization | Fibrillation | Ischemia | Stratigraphy | Thromboembolism | Drug dosages | Age | Vitamin K | Creatinine | Anticoagulants | Cerebral infarction | Stroke | Warfarin | Kidneys | Diabetes mellitus | Regression analysis | Patients | Tobacco | Infarction | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 06/2019, Volume 155, Issue 6, pp. 1199 - 1216
The efficacy and safety of direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) during extended anticoagulation for a VTE remains largely... 
mortality | extended anticoagulation | VTE | direct oral anticoagulant | vitamin K antagonist
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 04/2008, Volume 6, Issue 4, pp. 622 - 631
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 160, Issue 4, pp. 635 - 641.e2
Journal Article